Politics

DOJ and HHS announced on October 22 a six-month pilot program inviting healthcare companies to voluntarily self-disclose potential False Claims Act violations. The program is aimed at strengthening anti-fraud enforcement while creating a structured pathway for providers and companies to report misconduct. As a federal enforcement initiative involving major health agencies, it is a notable healthcare politics development with implications for compliance, oversight, and administration priorities.

KFF updated its polling dashboard on October 20 with new data on public trust in the CDC, FDA, state health officials, HHS Secretary Robert F. Kennedy Jr., and President Trump. The findings add fresh insight into how Americans view government health authorities and how those views vary across partisan lines. The update is relevant to healthcare politics because trust in public institutions can shape public response to health policy, regulation, and official guidance.

The White House issued an executive order on October 19, 2026 creating a Women’s Health Task Force and setting a new administration-wide policy framework on women’s health. The order also revokes prior Biden-era women’s health actions, making it a clear shift in federal healthcare policy direction through executive action. As a politics story, it centers on how the administration is redefining priorities and coordination across the federal government.

CMS said on October 15, 2026 that it is offering resources and regulatory flexibilities tied to a declared public health emergency in Alabama and Florida. The notice also includes Marketplace enrollment relief, showing how federal health agencies can use administrative tools to respond quickly during emergencies. The item is politically relevant because it reflects executive branch implementation of healthcare policy in crisis conditions.

A new KFF poll examines how healthcare is shaping voter attitudes ahead of the 2026 midterm elections, including views on healthcare costs, which party voters trust more on the issue, and support for Medicare-for-all. The findings add fresh public-opinion data to the political debate over healthcare, with implications for campaign messaging and issue priorities. Because this poll is specifically framed around the run-up to the 2026 election, it is materially distinct from earlier KFF polling already covered.

Sen. Cory Booker reintroduced the John Lewis EMMT Act on September 30 to require CMMI to include health-disparities expertise when developing Medicare and Medicaid payment models. The bill seeks to embed equity considerations directly into federal payment reform design rather than treating them as a separate policy track. It highlights an ongoing Democratic push to shape value-based care around disparities reduction.

Sens. Mark Warner and Bill Cassidy reintroduced bipartisan legislation on September 29 to expand federal drug acquisition cost surveys to specialty and mail-order pharmacies. The senators argue better reimbursement data would improve payment policy and help protect patients from higher out-of-pocket costs. The bill has implications for both Medicare and Medicaid drug reimbursement debates.

House and Senate Democrats introduced the No Surprise Bills for Seniors Act on September 24, aiming to shield Medicare Part D enrollees from losing drug coverage after unexpected premium increases. The measure focuses on a specific gap in beneficiary protections rather than broader surprise-billing policy. It adds to election-season pressure around prescription affordability and seniors’ coverage stability.

Sen. Mark Warner unveiled a broad health reform bill on September 24 that would address ACA subsidies, a public option, Medicare drug pricing, Medicaid, PBM practices, and price transparency. The proposal is notable for bundling multiple long-running health policy debates into one legislative package. As introduced, it serves as a major Democratic marker on costs, coverage, and federal health program reform.

Sens. Ben Ray Luján and Tom Cotton announced bipartisan legislation on September 23 to change how Medicare coverage determinations are made. According to the release, the bill would set clearer timelines, increase transparency, and strengthen CMS oversight of the process. The proposal targets delays and administrative barriers that can affect whether beneficiaries receive needed care promptly.

Senate appropriators’ minority leaders Patty Murray and Tammy Baldwin said they are concerned the Trump administration may redirect or impound congressionally approved funding for the Agency for Healthcare Research and Quality. The release frames the dispute as an oversight and separation-of-powers conflict over healthcare research funding near the end of the fiscal year. It stands apart from the previously published items because it centers on congressional scrutiny of federal research dollars rather than program funding announcements or public opinion polling.

House Appropriations Democrats warned that the administration may withhold or divert healthcare research funding for AHRQ as the fiscal year deadline approaches. The statement presents the issue as a conflict between Congress and the executive branch over whether appropriated research money will be spent as lawmakers intended. This is a separate political oversight item from other published healthcare funding stories because it focuses on a partisan budget dispute over federal research support.

The House Energy and Commerce Committee said its health subcommittee held a hearing on Medicare provider payment challenges and efforts to strengthen cybersecurity across the healthcare system. The hearing signals ongoing legislative attention to provider finances and digital security as healthcare policy priorities. It is materially different from the already published items because it covers congressional policy deliberations rather than agency funding awards, polling, or enforcement actions.

CMS announced nearly $17 million for Kansas through the Rural Health Transformation Program to support adoption of emerging health care technologies and improve patient transportation between facilities. The funding represents a distinct federal rural-health policy action with a state-specific focus. It differs from the already published titles, which centered on KFF polling about health care costs and the midterms.

CMS announced $11.7 million in rural-health funding for Vermont aimed at expanding access, improving patient care facilities, and strengthening workforce capacity in nursing homes and the long-term care system. The announcement is a separate administration policy item focused on rural care infrastructure and staffing. It is materially different from previously published election-related polling coverage.

CMS announced $4.8 million for West Virginia to strengthen the rural health care workforce and expand preventive care, including support tied to home dialysis access and transportation. The release presents a distinct federal health policy and funding development with implications for rural service delivery. It is separate from previously covered KFF polling on health care costs and midterm politics.

CMS announced enforcement actions against 11 medical equipment suppliers over suspected fraudulent Medicare Advantage and Part D billing totaling about $3.4 billion. The action highlights a major federal anti-fraud initiative in health care administration rather than a campaign or polling story. It is materially different from previously covered KFF election-focused health cost polling items.

This KFF poll focuses on how health care affordability is influencing voter preferences in the 2026 midterm cycle. It adds updated public opinion data on the political weight of health costs and the role the issue may play in electoral choices. The findings help explain why health care remains central in campaign strategy and policy messaging.

KFF reports that health care costs remain a salient political issue heading into the 2026 midterms, with the poll also testing reactions to expiring ACA tax credits. The findings highlight how voters view affordability pressures and which party they trust more on health issues. As a public opinion snapshot, the poll is relevant to campaign messaging and congressional debate over health policy.